IGF-1 LR3 is a recombinant Long Arg3 Insulin-like Growth Factor-1 peptide developed using advanced recombinant DNA (rDNA) technology. Engineered with an extended half-life and enhanced biological activity, it is designed to support lean muscle development, tissue regeneration, recovery, body recomposition, and athletic performance. IGF-1 LR3 (Long Arg3 Insulin-like Growth Factor-1) is a modified analogue of naturally occurring IGF-1 with a significantly longer half-life than native IGF-1. This structural modification reduces its binding to IGF-binding proteins, allowing greater bioavailability and prolonged receptor activity. After administration, IGF-1 LR3 binds to IGF-1 receptors in skeletal muscle and connective tissues, activating cellular pathways involved in protein synthesis, muscle cell proliferation, and tissue regeneration. It supports both muscle hypertrophy (increase in muscle fiber size) and muscle hyperplasia (formation of new muscle cells), while also assisting the repair of tendons, ligaments, and connective tissues. Combined with proper nutrition and resistance training, IGF-1 LR3 helps promote lean muscle development, recovery, and overall physical performance. IGF-1 LR3 is commonly incorporated into performance and physique-focused protocols for: Dosage should be individualized according to training goals and professional guidance. General protocols commonly range from 25–50 mcg daily, administered via intramuscular or subcutaneous injection, with cycle durations generally not exceeding 8 weeks. Store unopened vials at 2–8°C, protect from direct sunlight, and refrigerate after reconstitution. Avoid freezing and maintain proper aseptic handling during preparation and administration. IGF-1 LR3 is generally well tolerated when used appropriately. Some individuals may experience mild injection-site irritation, headache, fatigue, temporary changes in blood glucose levels, or localized discomfort. If severe or persistent adverse effects occur, discontinue use and consult a qualified healthcare professional. IGF-1 LR3 should be used only under professional medical supervision. Individuals with diabetes, impaired glucose tolerance, thyroid disorders, active malignancies, or other significant medical conditions should consult a healthcare provider before use. Regular monitoring of blood glucose and overall health is recommended during prolonged administration. IGF-1 LR3 is commonly incorporated into lean muscle gain, recovery, and body recomposition protocols. It is frequently combined with recombinant Human Growth Hormone (Somatropin) as part of advanced performance programs. Stacking strategies should always be individualized according to training goals and undertaken under appropriate professional guidance. The information provided is for educational purposes only and is not intended as medical advice. Use IGF-1 LR3 only under professional supervision. Product images are for illustration purposes only and may differ from the actual product. Packaging and labeling are subject to change without prior notice.IGF-1 LR3
Insulin-like Growth Factor-1 LR3 – 300 mcg
How It Works
Frequently Used For
Dosage & Storage
Possible Side Effects
Precautions
Stacking Compatibility
Disclaimer